ANTHONY DELOSREYES

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Psychiatric/Mental Health SEATTLE, WA NPI 1699324129

General Payments — all program years on this page

$5,864.30

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 100
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $1,576.62 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $1,576.6220

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $1,253.8931
2022 $1,691.7025
2023 $1,342.0924
2024 $1,576.6220

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1078245857 Janssen Pharmaceuticals, Inc $177.40 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1078246023 Janssen Pharmaceuticals, Inc $35.94 02/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1084827889 Noven Therapeutics, LLC $17.26 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101834958 E.R. Squibb & Sons, L.L.C. $147.52 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119057712 Otsuka America Pharmaceutical, Inc. $122.68 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119057714 Otsuka America Pharmaceutical, Inc. $107.55 11/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120489331 Alkermes, Inc. $119.72 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133939180 Vanda Pharmaceuticals Inc. $115.72 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148337525 Axsome Therapeutics, Inc. $118.32 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1148337527 Axsome Therapeutics, Inc. $123.83 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150926323 Neurocrine Biosciences, Inc. $88.94 06/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150926419 Neurocrine Biosciences, Inc. $86.87 03/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150929991 Neurocrine Biosciences, Inc. $37.47 09/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150935210 Neurocrine Biosciences, Inc. $32.44 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150936506 Neurocrine Biosciences, Inc. $31.63 05/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150941707 Neurocrine Biosciences, Inc. $29.19 01/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150943407 Neurocrine Biosciences, Inc. $28.60 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150955297 Neurocrine Biosciences, Inc. $24.97 03/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151019702 Neurocrine Biosciences, Inc. $6.74 03/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151592661 Teva Pharmaceuticals USA, Inc. $123.83 07/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.